Home
PGEN
PGEN News

Latest Precigen Inc. (PGEN) News on November 4, 2025

MT Newswires

22 days ago

Sector Update: Health Care Stocks Higher Premarket Monday

MT Newswires

22 days ago

Precigen Says Drug for Rare Respiratory Disease Shows Durable Outcomes

Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis

PR Newswire

22 days ago

Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis

4 years from clinic to approval — Precigen’s ‘unprecedented’ FDA nod and what comes next

Pharma Voice

2 months ago

4 years from clinic to approval — Precigen’s ‘unprecedented’ FDA nod and what comes next

EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS

PR Newswire

2 months ago

EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS

Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism

Insider Monkey

2 months ago

Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism

High Growth Tech Stocks To Watch In The US June 2025

Simply Wall St.

5 months ago

High Growth Tech Stocks To Watch In The US June 2025

Precigen, Inc.'s (NASDAQ:PGEN) market cap touched US$455m last week, benefiting both private equity firms who own 33% as well as institutions

Simply Wall St.

5 months ago

Precigen, Inc.'s (NASDAQ:PGEN) market cap touched US$455m last week, benefiting both private equity firms who own 33% as well as institutions

Precigen First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

Precigen First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Precigen Reports First Quarter 2025 Financial Results and Business Updates

PR Newswire

6 months ago

Precigen Reports First Quarter 2025 Financial Results and Business Updates

Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th

PR Newswire

7 months ago

Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th

Exploring US High Growth Tech Stocks This April 2025

Simply Wall St.

7 months ago

Exploring US High Growth Tech Stocks This April 2025

Precigen, Inc.'s (NASDAQ:PGEN) Profit Outlook

Simply Wall St.

7 months ago

Precigen, Inc.'s (NASDAQ:PGEN) Profit Outlook

Precigen Inc (PGEN) Q4 2024 Earnings Report Preview: What To Expect

GuruFocus.com

7 months ago

Precigen Inc (PGEN) Q4 2024 Earnings Report Preview: What To Expect

Precigen Reports Full Year 2024 Financial Results and Business Updates

PR Newswire

8 months ago

Precigen Reports Full Year 2024 Financial Results and Business Updates

Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th

PR Newswire

8 months ago

Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th

Exploring High Growth Tech Stocks In The US Market

Simply Wall St.

8 months ago

Exploring High Growth Tech Stocks In The US Market

Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025

Insider Monkey

8 months ago

Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025

PR Newswire

8 months ago

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025

Exploring 3 High Growth Tech Stocks in the United States

Simply Wall St.

9 months ago

Exploring 3 High Growth Tech Stocks in the United States

Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire

10 months ago

Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference

Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire

10 months ago

Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Exploring 3 Prominent High Growth Tech Stocks In The United States

Simply Wall St.

10 months ago

Exploring 3 Prominent High Growth Tech Stocks In The United States

Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis

PR Newswire

10 months ago

Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis

Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock

PR Newswire

10 months ago

Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock

Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86%

Simply Wall St.

a year ago

Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86%

Precigen Reports Third Quarter 2024 Financial Results and Business Updates

PR Newswire

a year ago

Precigen Reports Third Quarter 2024 Financial Results and Business Updates

Precigen to Participate in the Stifel 2024 Healthcare Conference

PR Newswire

a year ago

Precigen to Participate in the Stifel 2024 Healthcare Conference

High Growth Tech Stocks To Watch In October 2024

Simply Wall St.

a year ago

High Growth Tech Stocks To Watch In October 2024

Precigen to Participate in the 2024 Cantor Global Healthcare Conference

PR Newswire

a year ago

Precigen to Participate in the 2024 Cantor Global Healthcare Conference

While institutions own 26% of Precigen, Inc. (NASDAQ:PGEN), private equity firms are its largest shareholders with 43% ownership

Simply Wall St.

a year ago

While institutions own 26% of Precigen, Inc. (NASDAQ:PGEN), private equity firms are its largest shareholders with 43% ownership

Precigen Second Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

a year ago

Precigen Second Quarter 2024 Earnings: Misses Expectations

Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates

PR Newswire

a year ago

Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates

Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th

PR Newswire

a year ago

Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th

Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock

PR Newswire

a year ago

Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock

Precigen Announces Proposed $30 Million Public Offering of Common Stock

PR Newswire

a year ago

Precigen Announces Proposed $30 Million Public Offering of Common Stock

Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch

PR Newswire

a year ago

Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch

Precigen, Inc.'s (NASDAQ:PGEN) Shift From Loss To Profit

Simply Wall St.

a year ago

Precigen, Inc.'s (NASDAQ:PGEN) Shift From Loss To Profit

Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch

PR Newswire

a year ago

Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch

Precigen Insiders Added US$1.72m Of Stock To Their Holdings

Simply Wall St.

a year ago

Precigen Insiders Added US$1.72m Of Stock To Their Holdings

Is Precigen (NASDAQ:PGEN) In A Good Position To Invest In Growth?

Simply Wall St.

a year ago

Is Precigen (NASDAQ:PGEN) In A Good Position To Invest In Growth?

Precigen (NASDAQ:PGEN) shareholders are up 15% this past week, but still in the red over the last three years

Simply Wall St.

a year ago

Precigen (NASDAQ:PGEN) shareholders are up 15% this past week, but still in the red over the last three years

Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response

PR Newswire

a year ago

Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response

Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual Meeting

PR Newswire

a year ago

Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual Meeting

Precigen Reports First Quarter 2024 Financial Results and Business Updates

PR Newswire

a year ago

Precigen Reports First Quarter 2024 Financial Results and Business Updates

Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting

PR Newswire

a year ago

Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting

Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting

PR Newswire

2 years ago

Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting

Actym Therapeutics Appoints Thomas Smart as CEO

PR Newswire

2 years ago

Actym Therapeutics Appoints Thomas Smart as CEO

Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th

PR Newswire

2 years ago

Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th

Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript

GuruFocus.com

2 years ago

Precigen Inc (PGEN) Reports Full Year 2023 Financial Results

Precigen Reports Full Year 2023 Financial Results and Business Updates

PR Newswire

2 years ago

Precigen Reports Full Year 2023 Financial Results and Business Updates

Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis

PR Newswire

2 years ago

Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis

Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th

PR Newswire

2 years ago

Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th

Precigen, Inc. (NASDAQ:PGEN): When Will It Breakeven?

Simply Wall St.

2 years ago

Precigen, Inc. (NASDAQ:PGEN): When Will It Breakeven?

Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

PR Newswire

2 years ago

Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Insider Stock Buying Reaches US$1.72m On Precigen

Simply Wall St.

2 years ago

Insider Stock Buying Reaches US$1.72m On Precigen

Nabors Industries (NBR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

2 years ago

Nabors Industries (NBR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Best Income Stocks to Buy for January 29th

Zacks

2 years ago

Best Income Stocks to Buy for January 29th

Pagaya Closes New $400 Million Consumer Loan Deal, Reflecting Continued Strong Investor Demand

Business Wire

2 years ago

Pagaya Closes New $400 Million Consumer Loan Deal, Reflecting Continued Strong Investor Demand

Horizon Bancorp (IN) (HBNC) Reports Q4 and Full Year 2023 Results Amidst Strategic Balance ...

GuruFocus.com

2 years ago

Horizon Bancorp (IN) (HBNC) Reports Q4 and Full Year 2023 Results Amidst Strategic Balance ...

Schnitzer Steel Industries (NASDAQ:RDUS) Is Due To Pay A Dividend Of $0.1875

Simply Wall St.

2 years ago

Schnitzer Steel Industries (NASDAQ:RDUS) Is Due To Pay A Dividend Of $0.1875

AMC Networks to Report Fourth Quarter and Full Year 2023 Results

GlobeNewswire

2 years ago

AMC Networks to Report Fourth Quarter and Full Year 2023 Results

Three Bellwether REITs With Upcoming Earnings Reports To Watch

Benzinga

2 years ago

Three Bellwether REITs With Upcoming Earnings Reports To Watch

New Study Highlights Significant Potential Medicare Savings Through Use of Castle Biosciences’ DecisionDx®-SCC Test to Guide Adjuvant Radiation Therapy Decisions in Patients with Cutaneous Squamous Cell Carcinoma

Business Wire

2 years ago

New Study Highlights Significant Potential Medicare Savings Through Use of Castle Biosciences’ DecisionDx®-SCC Test to Guide Adjuvant Radiation Therapy Decisions in Patients with Cutaneous Squamous Cell Carcinoma

The Best Performing REITs of 2023: Mastering Dividends and Dominating the Market

Benzinga

2 years ago

The Best Performing REITs of 2023: Mastering Dividends and Dominating the Market

Pagaya Announces Timing of Fourth Quarter 2023 Earnings Release

Business Wire

2 years ago

Pagaya Announces Timing of Fourth Quarter 2023 Earnings Release

Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission

PR Newswire

2 years ago

Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission

Clearwater Paper Suspended Idaho Operations Due to Severe Weather Conditions

Business Wire

2 years ago

Clearwater Paper Suspended Idaho Operations Due to Severe Weather Conditions

AMC Networks (NASDAQ:AMCX) Could Be Struggling To Allocate Capital

Simply Wall St.

2 years ago

AMC Networks (NASDAQ:AMCX) Could Be Struggling To Allocate Capital

Overseas Shipholding Group Pledges $90,000 to Massachusetts Maritime Academy Foundation

Business Wire

2 years ago

Overseas Shipholding Group Pledges $90,000 to Massachusetts Maritime Academy Foundation

BrightSphere to Report Financial and Operating Results for the Fourth Quarter Ended December 31, 2023

Business Wire

2 years ago

BrightSphere to Report Financial and Operating Results for the Fourth Quarter Ended December 31, 2023

At US$61.47, Is It Time To Put Bel Fuse Inc. (NASDAQ:BELF.A) On Your Watch List?

Simply Wall St.

2 years ago

At US$61.47, Is It Time To Put Bel Fuse Inc. (NASDAQ:BELF.A) On Your Watch List?

Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

2 years ago

Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference

Associated Press Finance

2 years ago

Schnitzer Steel: Fiscal Q1 Earnings Snapshot

Liberty Media Corporation Completes Acquisition of Quint

Business Wire

2 years ago

Liberty Media Corporation Completes Acquisition of Quint

Pennant and John Muir Health Enter into a Home Health Joint Venture in the Bay Area, California

GlobeNewswire

2 years ago

Pennant and John Muir Health Enter into a Home Health Joint Venture in the Bay Area, California

Here's Why Investors Should Retain MGM Resorts (MGM) Stock

Zacks

2 years ago

Here's Why Investors Should Retain MGM Resorts (MGM) Stock

Even after rising 15% this past week, Precigen (NASDAQ:PGEN) shareholders are still down 86% over the past three years

Simply Wall St.

2 years ago

Even after rising 15% this past week, Precigen (NASDAQ:PGEN) shareholders are still down 86% over the past three years

Is Arista Networks (ANET) Stock Outpacing Its Computer and Technology Peers This Year?

Zacks

2 years ago

Is Arista Networks (ANET) Stock Outpacing Its Computer and Technology Peers This Year?

Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

GlobeNewswire

2 years ago

Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

2 years ago

Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference

10 Very Cheap Energy Stocks Ready To Explode

Insider Monkey

2 years ago

10 Very Cheap Energy Stocks Ready To Explode

Shore Bancshares (SHBI) Soars 7.3%: Is Further Upside Left in the Stock?

Zacks

2 years ago

Shore Bancshares (SHBI) Soars 7.3%: Is Further Upside Left in the Stock?

HomeTrust Bancshares (HTBI) Soars 5.4%: Is Further Upside Left in the Stock?

Zacks

2 years ago

HomeTrust Bancshares (HTBI) Soars 5.4%: Is Further Upside Left in the Stock?

Abacus Life Announces $15 Million Stock Repurchase Program

GlobeNewswire

2 years ago

Abacus Life Announces $15 Million Stock Repurchase Program

Legacy Housing (NASDAQ:LEGH) shareholders have earned a 14% CAGR over the last five years

Simply Wall St.

2 years ago

Legacy Housing (NASDAQ:LEGH) shareholders have earned a 14% CAGR over the last five years

Compass Pathways appoints Teri Loxam as Chief Financial Officer

GlobeNewswire

2 years ago

Compass Pathways appoints Teri Loxam as Chief Financial Officer

Wall Street Analysts See a 25.69% Upside in Legacy Housing (LEGH): Can the Stock Really Move This High?

Zacks

2 years ago

Wall Street Analysts See a 25.69% Upside in Legacy Housing (LEGH): Can the Stock Really Move This High?

Cool Company Ltd.: 2023 AGM Results Notification

Business Wire

2 years ago

Cool Company Ltd.: 2023 AGM Results Notification

Precigen to Participate in the JMP Securities Hematology and Oncology Summit

PR Newswire

2 years ago

Precigen to Participate in the JMP Securities Hematology and Oncology Summit

Key Information Relating to the Cash Dividend to Be Paid by Cool Company Ltd. (TICKER: CLCO)

Business Wire

2 years ago

Key Information Relating to the Cash Dividend to Be Paid by Cool Company Ltd. (TICKER: CLCO)

After Golden Cross, OraSure Technologies (OSUR)'s Technical Outlook is Bright

Zacks

2 years ago

After Golden Cross, OraSure Technologies (OSUR)'s Technical Outlook is Bright

Independent Director of ATN International Pamela Lenehan Buys 86% More Shares

Simply Wall St.

2 years ago

Independent Director of ATN International Pamela Lenehan Buys 86% More Shares

BrightView Holdings, Inc. (NYSE:BV) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

BrightView Holdings, Inc. (NYSE:BV) Q4 2023 Earnings Call Transcript

Is Now The Time To Look At Buying Aris Water Solutions, Inc. (NYSE:ARIS)?

Simply Wall St.

2 years ago

Is Now The Time To Look At Buying Aris Water Solutions, Inc. (NYSE:ARIS)?

Yalla Group Limited to Report Third Quarter 2023 Financial Results on November 20, 2023 Eastern Time

PR Newswire

2 years ago

Yalla Group Limited to Report Third Quarter 2023 Financial Results on November 20, 2023 Eastern Time

Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs

PR Newswire

2 years ago

Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs

Sotherly Hotels Inc. (SOHO) Reports Mixed Q3 2023 Results Amidst Market Challenges

GuruFocus.com

2 years ago

Sotherly Hotels Inc. (SOHO) Reports Mixed Q3 2023 Results Amidst Market Challenges

Precigen to Participate in the Stifel 2023 Healthcare Conference

PR Newswire

2 years ago

Precigen to Participate in the Stifel 2023 Healthcare Conference

Share on Social Networks: